Skip to main content

Table 1 Demographic and biochemical characteristics of study participants

From: The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins

  CHD patients Healthy controls P
  n=60 n=60  
Age (years) 60.42±8.75 61.09±8.87 NS
Male/Female 44/16 42/18 NS
BMI (kg/m2) 24.59±3.36 24.63±2.91 NS
Smoking cases (yes/no) 38/22 36/24 NS
TG (mmol/L) 1.75±0.91 1.33±0.68 0.041a
TC (mmol/L) 4.48±1.01 4.19±0.92 NS
HDL-C (mmol/L) 1.04±0.29 1.20±0.28 0.018a
LDL-C (mmol/L) 2.78±1.10 2.24±0.71 0.036a
FBS (mmol/L) 6.49±3.06 5.94±2.79 NS
BUN (mmol/L) 5.51±1.80 5.67±1.40 NS
Cr (umol/L) 81.61±19.33 78.85±16.87 NS
ALT (mmol/L) 24.68±9.99 20.58±8.21 NS
AST (mmol/L) 26.79±9.45 24.24±7.44 NS
ACE inhibitor or ARB (%) 36 (60%) 0 (0%)  
Beta-blocker (%) 49 (82%) 0 (0%)  
Statin (%) 60 (100%) 0 (0%)  
Aspirin (%) 60 (100%) 0 (0%)  
Clopidogrel (%) 15 (25%) 0 (0%)  
  1. aP < 0.05; CHD: Coronary heart disease; BMI: body mass index; TG: triglyceride; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; FBS: fasting blood glucose; BUN: blood urea nitrogen; Cr: serum creatinine; ALT: alanine aminotransferase; AST: aspartate aminotransferase; NS: not significant.